3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
3
Respiratory Tract Diseases
1
Osteosarcoma
1
Neoplasms
1
Neoplasm Metastasis
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
EGFR-mutant Non-small Cell Lung Cancer
1
Brain Neoplasms
1
Interventions
pembrolizumab
59
Cisplatin
44
Cetuximab
27
Radiotherapy
26
Carboplatin
24
Paclitaxel
16
Nivolumab
16
Docetaxel
16
Surveys and Questionnaires
15
Radiotherapy, Intensity-Modulated
13
Fluorouracil
12
Drug Therapy
12
Blood Specimen Collection
11
tislelizumab
7
cemiplimab
6
atezolizumab
6
Standard of Care
6
Radiation
6
Chemoradiotherapy
6
toripalimab
4
nimotuzumab
4
dostarlimab
4
Surgical Procedures, Operative
4
Cyclophosphamide
4
Afatinib
4
130-nm albumin-bound paclitaxel
4
palbociclib
3
niraparib
3
fludarabine
3
durvalumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Gefitinib
×
1 year
×
Clear all
No trials found.